Lawrence A. Kenyon

Director & Chief Financial Officer

Director & Chief Financial Officer at Outlook Therapeutics, Inc., filing insider transactions on 2026-08-14.

Total Purchases

—

1 transaction

Total Sales

—

0 transactions

Companies Traded

1 total filings

Active Since

2026-08-14

Last: 2026-08-14

Companies

Outlook Therapeutics, Inc.

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-08-14	OTLK	Purchase	101.0K	—	—	107.0K	SEC ↗